Literature DB >> 224070

Long acting cAMP analogues enhance sulfate incorporation into matrix proteoglycans and suppress cell division of fetal rat chondrocytes in monolayer culture.

R P Miller, M Husain, S Lohin.   

Abstract

The relationship between replication and the synthesis of matrix sulfated proteoglycans was investigated with fetal rat chondrocytes grown in monolayer culture. The effect of N6 O2' dibutyryl adenosine 3', 5' cyclic monophosphate (DBcAMP), adenosine 3', 5' cyclic monophosphate (cAMP), 8 Bromo adenosine 3', 5' cyclic monophosphate (8 Br-cAMP), sodium butyrate and hydroxyurea was examined. Between 0.05 and 0.5 mM DBcAMP, a dose related inhibition of cell division and stimulation of [35SO=/4] incorporation into matrix proteoglycans was demonstrated. At the higher concentrations of DBcAMP, cell division was completely inhibited and the enhancement of [35SO=/4] incorporation into matrix proteoglycans ranged between 40 and 120% (P less than 0.01). Utilizing 14C-glucosamine and photometric determination of proteoglycans with Alcian Blue, it was demonstrated that the increase in sulfate incorporation reflected enhanced accumulation of extracellular matrix. The effects of DBcAMP were mimicked by 8 Br-cAMP, suggesting they were mediated by the adenylyl cyclase system. cAMP (0.05-0.5 mM), sodium butyrate (0.1-0.5 mM) and hydroxyurea (0.5-5 mM) partially or fully inhibited cell division, but either failed or only slightly enhanced sulfate incorporation. The enhanced sulfated proteoglycan deposition promoted by DBcAMP began 8 to 12 hours after serum stimulation, its onset occurred prior to thymidine incorporation and the effect persisted for 28 hours. Determination of cell volume demonstrated an increase in size of DBcAMP treated chondrocytes between 8 to 12 hours, coincident with the onset of increased sulfate incorporation. These results are consistent with a model where matrix sulfated proteoglycan deposition by chondrocytes is mediated by intracellular cAMP levels and occurs in the G1 phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 224070     DOI: 10.1002/jcp.1041000107

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Cyclic AMP-regulating agents inhibit endotoxin-mediated cartilage degradation.

Authors:  M S Bednar; J R Hubbard; J J Steinberg; F A Broner; C B Sledge
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

2.  Regulation of glycosaminoglycan synthesis by thyroid hormone in vitro.

Authors:  T J Smith; Y Murata; A L Horwitz; L Philipson; S Refetoff
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

3.  Arachidonate metabolism during chondrogenesis in vitro.

Authors:  K P Chepenik; W C Ho; B M Waite; C L Parker
Journal:  Calcif Tissue Int       Date:  1984-03       Impact factor: 4.333

4.  The brachymorphic mutation of mice and altered developmental patterns of limb bud 3':5' cyclic adenosine monophosphate.

Authors:  D Hindin; R P Erickson
Journal:  Experientia       Date:  1981-11-15

5.  Restoration by cyclic AMP of the differentiated phenotype of chondrocytes from de-differentiated cells pretreated with retinoids.

Authors:  M Takigawa; T Takano; F Suzuki
Journal:  Mol Cell Biochem       Date:  1982-02-19       Impact factor: 3.396

6.  Inhibition of endothelial cell morphogenetic interactions in vitro by alpha- and beta-xylosides.

Authors:  A M Schor; S L Schor
Journal:  In Vitro Cell Dev Biol       Date:  1988-07

7.  Effect of vanadate on cartilage-matrix proteoglycan synthesis in rabbit costal chondrocyte cultures.

Authors:  Y Kato; M Iwamoto; T Koike; F Suzuki
Journal:  J Cell Biol       Date:  1987-02       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.